small molecule therapeutics for leukemia/neurodegenerative diseases/anemia (Carna Biosciences)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Namesmall molecule therapeutics for leukemia/neurodegenerative diseases/anemia (Carna Biosciences)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein kinases modulators
TargetsProtein kinases
Therapy Area/IndicationsNerve DegenerationAnemiaLeukemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCarna Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCarna Biosciences Inc
Active IndicationsN/A
Inactive IndicationsNerve DegenerationAnemiaLeukemia

Other Information

ATC CodeN/A
Related LinksN/A